Abs Khan
@abattacks.bsky.social
85 followers 19 following 26 posts
Research Fellow @ MRC WIMM. Permanent resident of tissue culture hood 82. Organoids, bone marrow and haematopoeisis by day. Heavy metal, climbing, bookworm also by day let’s be honest I’m too old to do anything in the evenings any more.
Posts Media Videos Starter Packs
Reposted by Abs Khan
abattacks.bsky.social
As a side note - I didn't think much of a 100km row over the whole month, but 10km in and I must say I am questioning my judgement/fitness/ability...
abattacks.bsky.social
Different flavour of post from me today!

A bunch of us in the lab at the @imm.ox.ac.uk are taking up Bone Cancer Research Trust (BCRT)'s June rowing challenge to both raise funds and awareness:

www.justgiving.com/fundraising/...

Please share/donate if you can!
HSCB lab rows 100km each for bone cancer research
Help Abdullah Khan raise money to support Bone Cancer Research Trust
www.justgiving.com
abattacks.bsky.social
Looking forward to it Zoltan - bring me some home cooking !
abattacks.bsky.social
I loved this course! If Aiden or Natalie are instructing say hi from me!
abattacks.bsky.social
😊🥹
imm.ox.ac.uk
Congratulations to MRC WIMM researchers Sarah, @abattacks.bsky.social, Pramila & Jack 🎉
rdm.ox.ac.uk
Congratulations to RDM's newly designated Principal Investigators for 2025! 🎉

Sarah Gooding
Sarah Howles
Abdullah Khan
Pramila Rijal
Jack Tan

Read more about our new PIs and their research 👇

www.rdm.ox.ac.uk/news/announc...

@imm.ox.ac.uk
Reposted by Abs Khan
alejofraticelli.bsky.social
🔥 New Fraticelli lab publication🔥

“Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemia driver mutations”

Now at Cell Stem Cell, with two new figures, in vivo, and sequential mutagenesis data.

Performed with the support of Cris Cancer and @erc.europa.eu
abattacks.bsky.social
Very kind of you Dianne, appreciated!
abattacks.bsky.social
Finally finally a big thank you to everyone who has engaged with and showed an interest in implementing the system. I am hopeful that we can make big strides forward as a community as these types of systems advance. Thank you to patients + funders!
abattacks.bsky.social
. If you're interested in implementing please join: groups.google.com/g/morerganoids
Where we help troubleshoot + share protocols etc.

And this is the playlist:
open.spotify.com/playlist/380...
To which the paper was written for everyone out there who writes/works to very specific music.
Bone Marrow Organoids - Google Groups
groups.google.com
abattacks.bsky.social
A lot of the major therapeutic challenges and many interesting questions are around clonal evolution, chemoresistance etc. To address those well we need longer lived, 'stable' cultures - we see a decline in complexity over time in our static cultures. Watch this space!
abattacks.bsky.social
I'll end on quoting @kellystevens.bsky.social 'It's not about how far we've come, but about how far we have left to go.' I hope you will agree this is a big step forward, but there are still challenges that I am excited to tackle (funding pending of course).
abattacks.bsky.social
... you can build in a lot of complexity and work out strategies to retain throughput and scalability.
abattacks.bsky.social
We present what we believe is a highly complex in vitro model that showcases the potential of human organoid systems. By adapting granular microgels pioneered by colleagues in the bioengineering field (e.g. J Burdick and others), I think we also show that...
abattacks.bsky.social
Finally that helps us identify an inflammatory pathway (MIF) which we think underpins myeloma mediated inflammation. We show that inhibiting this in myeloma-comBO chimeroids ameliorates markers of inflammation.
abattacks.bsky.social
We then apply this system as a pre-clinical model to study multiple myeloma - showing that we support primary myeloma cells (notoriously difficult to culture ex vivo) and capture hallmarks of their extensive interactions with bone marrow niches.
abattacks.bsky.social
In this manuscript we address these to present comBO: a combined bone and lympho-myeloid bone marrow organoid system (I know the acronym is a bit of a reach, but it's stuck now).
abattacks.bsky.social
(1) Capturing simultaneous lympho- and myelopoiesis in a single culture to better model haematopoiesis. (2) Generating the specialist osteoblastic niche and (3) circumventing the limitations imposed by bulk hydrogel embedding (cost, labour, scalability, automation).
abattacks.bsky.social
On to the science! Despite recent advances in developing bone marrow organoid systems (our own work in Cancer Discovery (2023) and Nature Protocols (2024) + Frenz-Weissner paper (Nature Methods, 2024), the major challenges (as we see them) remained:
abattacks.bsky.social
And of course @bethpsaila.bsky.social for all the support (and patience...). A big thank you to the whole HSCB lab for all the support which most often manifests as pranks/coffee/donuts...
abattacks.bsky.social
... it can still be fun so a huge thank you to everyone who made it so. In particular shout out to @yuqi-shen.bsky.social qi-shen.bsky.social without whose support it would have been impossible to do this. @Sarah Gooding for gentle guidance and excellent collaboration in the myeloma world.
abattacks.bsky.social
First and foremost, a huge thank you to all co-authors. This has been a tricky project to pull together having moved twice + juggling demands of grant writing/trying to set up a research group. With the support of lovely people in an excellent environment @imm.ox.ac.uk ...
abattacks.bsky.social
Still 😍🔥🔥🔥🔥